Protein Variant Interpretation

A single misspelling in a person's genetic code can turn a healthy protein into a disease-causing one, but scientists often cannot tell which mutations matter and which are harmless. This research tackles a fundamental gap in medical genetics: even when a DNA sequencing test finds a variant in a patient's genome, clinicians often have no way to know whether that variant actually causes disease. The problem is that existing tools each have blind spots. Computational predictors can flag damaging mutations but cannot explain *why* they are harmful. Structural models can reveal the molecular mechanism but are poor at identifying which variants are damaging in the first place. And high-throughput lab experiments called deep mutational scanning can do both, but only if designed correctly. The researchers are developing strategies to combine these three approaches—computational prediction, structural bioinformatics, and deep mutational scanning—into a single, efficient pipeline. If successful, this work would allow clinical geneticists to interpret thousands of rare variants with confidence, turning ambiguous sequencing results into actionable diagnoses. It could also reveal the precise molecular mechanisms by which specific mutations disrupt protein function, opening the door to targeted therapies. This is fundamental science with a direct clinical payoff: better diagnosis and, eventually, better treatment for people with genetic diseases.